Skip to main content

Verapamil Hydrochloride Extended-Release Capsules

Type of Posting: Revision Bulletin

Posting Date: 31–May–2013; updated 05–Jun–2013*

Official Date: 01–Jun–2013

Archive Date: 09–Feb–2015

Expert Committee: Monographs—Small Molecules 2

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Verapamil Hydrochloride Extended-Release Capsules monograph. The purpose of the revision is to add Dissolution Test 2 for other products approved by the FDA. This revision is also to indicate the optional use of the sinker depending on the Apparatus used in accordance with the FDA approved procedures.

The Verapamil Hydrochloride Extended-Release Capsules Revision Bulletin supersedes the currently official monograph. This Revision Bulletin will be incorporated in USP 37–NF 32.

Should you have any questions, please contact Sujatha Ramakrishna Ph.D., M.B.A. (301-816-8349 or sxr@usp.org).

* The Verapamil Hydrochloride Extended-Release Capsules Revision Bulletin PDF that was posted on May 31, 2013 was missing the definition list for the equation that appears in Dissolution Test 1. A corrected PDF of the Revision Bulletin was added on June 5, 2013.